explore -WSS

explore

author：leisure time 2025-09-30 20:18:40 - browse：38815

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Eyeing GLP

leisure time

explore

WSS

How to improve immunocompromised access to mAb treatments

Cue Health, Covid

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Researchers on aging grapple with how to calculate biological age

Use wet bulb globe temperature, not heat index, to protect workers

Bird flu surveillance in wastewater gets boost from consortium

hotspot

explore

hotspot

Guidelines to prevent youth baseball injuries need more muscle

H5N1 bird flu: what we're starting to learn about infection in cows

Trump demands the U.S. pay no more for drugs than other countries … again

H5N1 virus can be tracked in retail milk, scientists say

Drug repurposing or repositioning? The language matters

CDC wastewater surveillance dashboard to track bird flu hotspots

Supreme Court strikes down use of affirmative action

Making AI in medicine accessible to smaller, and rural hospitals

Dobbs anniversary: the lost opportunity of abortion as health care

Study: Adult vaccinations pay for themselves in societal benefits

knowledge

Cue Health, Covid

Steward Health Care files for bankruptcy

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Addressing health care workers' trauma can help fight burnout

Apple Watch's A

FDA poised to publish guidelines for clinical trial diversity

leisure time

leisure time

explore

leisure time